SCL on NYSE

Stepan Company

Logo: Stepan Company, Public domain, via Wikimedia Commons5

American company

Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.3 Its shares trade on NYSE under the symbol SCL.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

1932Founded1

Compare with Church & Dwight, Ecolab or Procter & Gamble, or pick any stock.

  • TickerSCL on NYSE1
  • Industrychemistry1
  • HeadquartersNorthfield1
  • Websitewww.stepan.com
  • Legal formDelaware corporation1
  • Incorporated inDE6
  • Business addressEdens & Winnetka Road, Northfield, Il 600936
  • Filer categoryLarge accelerated filer6
  • LEIIZU1EW9GB3WC7CYCSR174
  • StatusActive4
  • LEI statusIssued and current4
  • Registered addressC/O THE CORPORATION TRUST COMPANY, 19801 Wilmington, United States4
  • Registered withDivision of Corporations, Department of State, 5335114

Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

11.6%Gross margin9
3.4%Operating margin9
2.0%Net margin9
7.0%Revenue growth, 20259
3.8%Return on equity9
0.27×Debt to equity9
$25.4MFree cash flow9

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue88¢$2.1B
  • Research and development1¢$34.8M
  • Other costs8¢$175.2M
  • Income tax1¢$13.0M
  • Profit2¢$46.9M

Out of $2.3B in revenue.9

Where each dollar of operating cash went, fiscal 2025

  • Capital spending78¢$122.5M
  • Dividends paid22¢$35.0M

Out of $147.9M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.9

Financial statements

Revenue101112139$2.3B in 2025+25% since 2019
0$1.0B$2.0B$3.0B2019: $1.9B$1.9B20192020: $1.9B$1.9B2020+1%2021: $2.3B$2.3B2021+25%2022: $2.8B$2.8B2022+18%2023: $2.3B$2.3B2023−16%2024: $2.2B$2.2B2024−6%2025: $2.3B$2.3B2025+7%
Gross profit101112139$269.9M in 2025−21% since 2019
0$200.0M$400.0M$600.0M2019: $339.7M$339.7M20192020: $383.6M$383.6M2020+13%2021: $395.8M$395.8M2021+3%2022: $427.1M$427.1M2022+8%2023: $277.6M$277.6M2023−35%2024: $272.2M$272.2M2024−2%2025: $269.9M$269.9M2025−1%
Operating income101112139$78.5M in 2025−38% since 2019
0$100.0M$200.0M$300.0M2019: $127.3M$127.3M20192020: $171.5M$171.5M2020+35%2021: $170.8M$170.8M2021−0%2022: $207.3M$207.3M2022+21%2023: $58.6M$58.6M2023−72%2024: $70.5M$70.5M2024+20%2025: $78.5M$78.5M2025+11%
Net income101112139$46.9M in 2025−55% since 2019
0$50.0M$100.0M$150.0M2019: $103.1M$103.1M20192020: $126.8M$126.8M2020+23%2021: $137.8M$137.8M2021+9%2022: $147.2M$147.2M2022+7%2023: $40.2M$40.2M2023−73%2024: $50.4M$50.4M2024+25%2025: $46.9M$46.9M2025−7%
Fiscal year2019202020212022202320242025
Revenue$1.9B10$1.9B11$2.3B12$2.8B13$2.3B9$2.2B9$2.3B9
Cost of revenue$1.5B10$1.5B11$2.0B12$2.3B13$2.0B9$1.9B9$2.1B9
Gross profit$339.7M10$383.6M11$395.8M12$427.1M13$277.6M9$272.2M9$269.9M9
Research and development$34.1M10$36.0M11$38.8M12$40.9M13$35.7M9$33.5M9$34.8M9
Operating expenses$221.7M12$218.4M13$205.0M9$201.7M9$201.0M9
Operating income$127.3M10$171.5M11$170.8M12$207.3M13$58.6M9$70.5M9$78.5M9
Interest
Income before tax$172.5M12$188.7M13$48.4M9$60.4M9$59.9M9
Income tax$22.8M10$43.4M11$34.6M12$41.5M13$8.2M9$10.1M9$13.0M9
Net income$103.1M10$126.8M11$137.8M12$147.2M13$40.2M9$50.4M9$46.9M9
Earnings per share$4.4710$5.5211$6.0112$6.4613$1.779$2.219$2.059
Earnings per share (diluted)$4.4210$5.4511$5.9212$6.3813$1.759$2.209$2.059
Shares (weighted, basic)22.9M shares1222.8M shares1322.8M shares922.8M shares922.9M shares9
Shares (weighted, diluted)23.3M shares1223.1M shares1322.9M shares922.9M shares922.9M shares9

Compare Stepan Company with another company

Corporate structure

Stepan Company sits at the top of its group. 23 entities, 15 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Stepan Company

  • Stepan Company Northbrook, Illinois, United States
    • Stepan (India) Private Limited Subsidiary · India
    • Stepan (Nanjing) Chemical R&D Co., Ltd. Subsidiary · China
    • Stepan Asia Pte. Ltd. Subsidiary · Singapore
    • STEPAN CANADA SALES INC. Subsidiary · Vancouver, British Columbia, Canada
    • Stepan CDMX, S. de R.L. de C.V. Subsidiary · Mexico
    • Stepan Chemical (Nanjing) Co., Ltd. Subsidiary · China
    • Stepan Chemical (Shanghai) Co., Ltd. Subsidiary · China
    • Stepan Colombia S.A.S. Subsidiary · Colombia
    • Stepan Deutschland GmbH Subsidiary · Germany
    • Stepan Europe S.A.S. Subsidiary · France
    • Stepan Holdings Asia Pte. Ltd. Subsidiary · Singapore
    • Stepan Holdings Netherlands B.V. Subsidiary · Netherlands
    • Stepan Mexico, S.A. de C.V. Subsidiary · Mexico
    • Stepan Netherlands B.V. Subsidiary · Netherlands
    • Stepan Philippines Quaternaries, Inc. Subsidiary · Philippines
    • Stepan Philippines, Inc. Subsidiary · Philippines
    • Stepan Poland Sp. z o.o. Subsidiary · Poland
    • Stepan Polska Sp. z o.o. Subsidiary · Poland
    • Stepan Química Argentina S.R.L. Subsidiary · Argentina
    • Stepan Química Ltda. Subsidiary · Brazil
    • Stepan Specialty Products B.V. Subsidiary · Netherlands
    • Stepan UK Limited Subsidiary · United Kingdom

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Stepan Company reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Land$58.4M9 Dec 31, 2025$54.5M9 Dec 31, 2024+7.2%
Buildings and improvements$455.1M9 Dec 31, 2025$399.2M9 Dec 31, 2024+14.0%
Machinery and equipment$2.2B9 Dec 31, 2025$1.9B9 Dec 31, 2024+12.7%
Construction in progress$112.9M9 Dec 31, 2025$275.0M9 Dec 31, 2024−59.0%
Property and equipment, before depreciation$2.8B9 Dec 31, 2025$2.6B9 Dec 31, 2024+5.3%
Accumulated depreciation$1.6B9 Dec 31, 2025$1.4B9 Dec 31, 2024+8.3%
Property and equipment, net$1.2B9 Dec 31, 2025$1.2B9 Dec 31, 2024+1.8%
Operating-lease assets (leased space)$62.5M9 Dec 31, 2025$71.5M9 Dec 31, 2024−12.6%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$132.7M9 Dec 31, 2025$99.7M9 Dec 31, 2024+33.1%
Long-term investments$21.3M9 Dec 31, 2025$25.6M9 Dec 31, 2024−16.8%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$92.6M9 Dec 31, 2025$91.4M9 Dec 31, 2024+1.3%
Intangible assets, net (excluding goodwill)$39.5M9 Dec 31, 2025$42.7M9 Dec 31, 2024−7.4%
Indefinite-lived intangibles (excluding goodwill)$09 Dec 31, 2025$013 Dec 31, 2024
Accumulated amortization$58.7M9 Dec 31, 2025$51.1M9 Dec 31, 2024+14.9%

Inventory

ItemLatestA year beforeChange
Inventory, total$298.8M9 Dec 31, 2025$288.7M9 Dec 31, 2024+3.5%
Raw materials$78.7M9 Dec 31, 2025$87.0M9 Dec 31, 2024−9.5%
Finished goods$220.1M9 Dec 31, 2025$201.7M9 Dec 31, 2024+9.1%

Properties, in its own words

The following are the Company’s principal physical properties. Unless otherwise noted, the listed properties are owned by the Company. Management believes that the Company’s facilities are suitable and adequate for the Company’s current operations.

Name of Facility · Location · Site Size · Segment

The rest of Item 2

1. · Millsdale · Elwood, Illinois · 492 acres · Surfactants/Polymers

2. · Winder · Winder, Georgia · 202 acres · Surfactants

3. · Maywood · Maywood, New Jersey · 19 acres · Surfactants /Specialty Products

4. · Pasadena · Pasadena, Texas · 51 acres · Surfactants

5. · Stepan France · Voreppe, France · 20 acres · Surfactants

6. · Stepan Ecatepec · Ecatepec, Mexico · 34 acres · Surfactants

7. · Stepan China · Nanjing, China (Nanjing Chemical Industrial Park) · 13 acres (right of use arrangement) · Polymers

8. · Stepan Brazil · Vespasiano, Minas Gerais, Brazil · 27 acres · Surfactants

9. · Global Technology Center · Northfield, Illinois · 8 acres · N/A

10. · Company Headquarters · Northbrook, Illinois · 1.72 acres (leased) · N/A

Item 2 of the 10-K filed Feb 26, 2026.19

The story

In its earliest days, Stepan Company was just Alfred C. Stepan Jr., who began distributing chemical products to control road dust on country roads in Illinois. His first location was a rented desk at Chicago’s North Pier Terminal.

From Wikipedia’s article on Stepan Company, shared under CC BY-SA 4.0.7

Leadership

Who has led Stepan Company, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (48)

Products and brands

Stepan produces a wide array of industrial chemicals used as raw materials to make end products in the following industries: agriculture, antimicrobial, beverages, construction, dietary supplements, emulsion polymerization, flavors, food, household, institutional, and industrial cleaning, industrial products, laundry and cleaning, nutrition, nutritional powders, oilfield, personal care, pharmaceutical, phthalic anhydride, and polyester polyols (for coatings, adhesives, sealants, elastomers, powder coating resins, and rigid foam).

From Wikipedia’s article on Stepan Company, shared under CC BY-SA 4.0.7

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • Stepan (India) Private Limited India8
  • Stepan (Nanjing) Chemical R&D Co., Ltd. China8
  • Stepan Asia Pte. Ltd. Singapore8
  • Stepan CDMX, S. de R.L. de C.V. Mexico8
  • Stepan Canada Sales Inc. Canada8
  • Stepan Chemical (Nanjing) Co., Ltd. China8
  • Stepan Chemical (Shanghai) Co., Ltd. China8
  • Stepan Colombia S.A.S. Colombia8
  • Stepan Deutschland GmbH Germany8
  • Stepan Europe S.A.S. France8
  • Stepan Holdings Asia Pte. Ltd. Singapore8
  • Stepan Holdings Netherlands B.V. Netherlands8
  • Stepan Mexico, S.A. de C.V. Mexico8
  • Stepan Netherlands B.V. Netherlands8
  • Stepan Philippines Quaternaries, Inc. Philippines8
  • Stepan Philippines, Inc. Philippines8
  • Stepan Poland Sp. z o.o. Poland8
  • Stepan Polska Sp. z o.o. Poland8
  • Stepan Química Argentina S.R.L. Argentina8
  • Stepan Química Ltda. Brazil8
  • Stepan Specialty Products B.V. Netherlands8
  • Stepan UK Limited United Kingdom8

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Timeline

  1. Sep 28, 20268-K Entered a material agreement; New debt or obligation77
  2. Jul 29, 20268-K Results of operations; Exit or restructuring costs; Executive or director change78
  3. Apr 30, 20268-K Shareholder vote79
  4. Apr 28, 20268-K Results of operations; Other events80
  5. Feb 23, 20268-K Results of operations; Other events81
  6. Feb 23, 20268-K Exit or restructuring costs; Regulation FD disclosure82
  7. Nov 28, 20258-K Executive or director change83
  8. Oct 29, 20258-K Other events84
  9. Oct 14, 20258-K Executive or director change85
  10. Jul 30, 20258-K Results of operations; Other events86
  11. Jul 14, 20258-K Executive or director change87
  12. Jun 9, 20258-K Executive or director change88
  13. Nov 12, 2024New chief executive Luis Rojo becomes CEO20
  14. Feb 16, 2023New chief executive Scott R. Behrens becomes CEO21
  15. Feb 16, 2006New chief executive F. Quinn Stepan Jr. becomes CEO22
  16. 1932Founded Founded1

Calendar

Coming up

  1. Oct 28, 2026 · Before the openReports results for the quarter ending Sep/2026 A year earlier it reported $0.48 a share, on Oct 29, 2025.89

When it reported results

  1. Jul 29, 2026Reported quarterly or annual results78
  2. Apr 28, 2026Reported quarterly or annual results80
  3. Feb 23, 2026Reported quarterly or annual results81
  4. Jul 30, 2025Reported quarterly or annual results86
  5. Feb 19, 2025Reported quarterly or annual results90
  6. Oct 30, 2024Reported quarterly or annual results91
  7. Jul 31, 2024Reported quarterly or annual results92
  8. Apr 30, 2024Reported quarterly or annual results93

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

405 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 47 major events, 267 insider forms, 17 large holders, 54 other. The latest 20:

  1. Oct 8, 2026SCHEDULE 13G EDGAR
  2. Sep 28, 20268-K EDGAR
  3. Aug 28, 20264 PRIMARY DOCUMENT EDGAR
  4. Aug 12, 20264 PRIMARY DOCUMENT EDGAR
  5. Aug 5, 202610-Q EDGAR
  6. Aug 4, 20263 PRIMARY DOCUMENT EDGAR
  7. Jul 29, 20268-K EDGAR
  8. May 29, 2026SD EDGAR
  9. May 12, 20264 PRIMARY DOCUMENT EDGAR
  10. May 12, 20264/A PRIMARY DOCUMENT EDGAR
  11. May 12, 20264/A PRIMARY DOCUMENT EDGAR
  12. May 12, 20264/A PRIMARY DOCUMENT EDGAR
  13. May 12, 20264/A PRIMARY DOCUMENT EDGAR
  14. May 12, 20264/A PRIMARY DOCUMENT EDGAR
  15. May 12, 20264/A PRIMARY DOCUMENT EDGAR
  16. May 12, 20264/A PRIMARY DOCUMENT EDGAR
  17. May 12, 20264 PRIMARY DOCUMENT EDGAR
  18. May 12, 20264 PRIMARY DOCUMENT EDGAR
  19. May 12, 20264 PRIMARY DOCUMENT EDGAR
  20. May 12, 20264 PRIMARY DOCUMENT EDGAR

The 405 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

37 open-market trades by officers, directors and large owners since October 2021: 3 buys and 34 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 5, 2025STEPAN F QUINN JRDirectorSale3,700$50.49$186.8KForm 4
Aug 4, 2025STEPAN F QUINN JRDirectorSale6,300$49.96$314.8KForm 4
Feb 25, 2025Lewis SusanDirectorBuy500$63.53$31.8KForm 4
Aug 14, 2024Kabbes DavidVP GC & SecretaryBuy1,056$71.39$75.4KForm 4
Mar 7, 2024STEPAN F QUINN JRDirectorSale2,000$87.43$174.9KForm 4
Mar 6, 2024STEPAN F QUINN JRDirectorSale2,000$86.58$173.2KForm 4
Mar 5, 2024STEPAN F QUINN JRDirectorSale1,000$87.48$87.5KForm 4
Feb 27, 2024STEPAN F QUINN JRDirectorSale6,363$89.58$570.0KForm 4
Feb 26, 2024STEPAN F QUINN JRDirectorSale3,637$90.11$327.7KForm 4
Feb 26, 2024Behrens Scott R.President & CEOSale950$89.77$85.3KForm 4
Feb 23, 2024Rojo LuisPresident & CEOSale600$91.29$54.8KForm 4
Feb 23, 2024Behrens Scott R.President & CEOSale700$90.93$63.7KForm 4
Feb 23, 2024STEPAN F QUINN JRDirectorSale5,000$91.07$455.4KForm 4
Feb 22, 2024STEPAN F QUINN JRDirectorSale5,000$91.55$457.8KForm 4
Aug 28, 2023Dearth Randall S.DirectorSale590$87.19$51.4KForm 4
Aug 1, 2023STEPAN F QUINN JRDirectorSale2,500$95.23$238.1KForm 4
Jul 31, 2023STEPAN F QUINN JRDirectorSale7,668$94.75$726.6KForm 4
May 26, 2023Mergner Arthur WExec VPSale3,987$93.34$372.1KForm 4
May 23, 2023Mergner Arthur WExec VPSale1,996$98.23$196.1KForm 4
May 4, 2023Behrens Scott R.President & CEOSale2,000$89.91$179.8KForm 4

All 37 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Luis E. RojoPresident and Chief Executive Officer$940.0K$4.3M99
2025Robert J. Haire, Jr.Executive Vice President, Supply Chain$484.2K$1.4M99
2025Sean T. MoriartyVice President and General Manager – Surfactants$486.3K$1.2M99
2025Richard StepanVice President and General Manager – Polymers$385.1K$963.3K99
2025Ruben VelasquezVice President and Chief Financial Officer$220.5K$715.6K99
2025Samuel S. HinrichsenFormer Interim Chief Financial Officer$270.1K$412.6K99
2024Luis E. RojoPresident and Chief Executive Officer$624.1K$3.0M99
2024Robert J. Haire, Jr.Executive Vice President, Supply Chain$470.4K$1.5M99
2024Sean T. MoriartyVice President and General Manager – Surfactants$472.4K$1.2M99
2024Samuel S. HinrichsenFormer Interim Chief Financial Officer$270.8K$378.6K99
2023Luis E. RojoPresident and Chief Executive Officer$540.8K$1.5M99
2023Sean T. MoriartyVice President and General Manager – Surfactants$458.3K$1.1M99
2023Robert J. Haire, Jr.Executive Vice President, Supply Chain$306.7K$941.2K99

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.3,458,328$192.7M0.0%+147,288
HighTower Advisors, LLC1,589,877$88.6M0.1%−188
Vanguard Portfolio Management LLC1,381,590$77.0M0.0%+22,737
Dimensional Fund Advisors LP1,125,025$62.7M0.0%+7,995
Vanguard Capital Management LLC949,949$52.9M0.0%+7,958
American Century Companies Inc948,532$52.9M0.0%+216,411
Deprince Race & Zollo Inc936,608$52.2M0.9%−10,844
State Street Corp888,716$49.5M0.0%−13,948
Geode Capital Management, LLC565,294$31.5M0.0%+35,734
Ameriprise Financial Inc433,582$24.2M0.0%+40,313
Charles Schwab Investment Management Inc406,851$22.7M0.0%−57,604
Two Sigma Investments, LP387,268$21.6M0.0%+59,446
Russell Investments Group, Ltd.308,835$17.2M0.0%−1,124
Aqr Capital Management LLC291,597$16.2M0.0%+56,935
Morgan Stanley279,408$15.6M0.0%−25,008
Northern Trust Corp272,862$15.2M0.0%+30,342
Cresset Asset Management, LLC223,081$12.4M0.0%−22
Nuveen, LLC205,903$11.5M0.0%+336
Goldman Sachs Group Inc205,494$11.5M0.0%−46,676
Algert Global LLC182,741$10.2M0.1%−8,054
Gotham Asset Management, LLC168,599$9.4M0.0%+94
Invesco Ltd.165,900$9.2M0.0%−6,838
Gendell Jeffrey L165,520$9.2M0.1%No change
UBS Group AG146,528$8.2M0.0%+76,218
Vanguard Fiduciary Trust Co143,140$8.0M0.0%+5,293

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Stepan Company is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARSTEPAN CO2
  • CIK0000094049
  • Employer ID (EIN)36-182383419
  • Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company19
  • Incorporated inDelaware19
  • Fiscal year endsDecember 312
  • Industry code (SIC)2840 Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics2
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance2
  • Business addressEdens & Winnetka Road, Northfield, IL 600932
  • Phone84744675002
  • Shares outstanding22,732,540 as of Aug 3, 202615
  • Public float$1.2B as of Jun 30, 202519
  • AuditorDELOITTE & TOUCHE LLP, Chicago, Illinois PCAOB ID 34; it also attests to the company’s internal control over financial reporting19
  • On EDGAR sinceFeb 10, 19942
  • Filings2,601 in all: 4 (1,829), 8-K (201), SC 13G/A (160), 10-Q (98), 4/A (50), 3 (38), 10-K (33), DEF 14A (32)2
    All 29 form types

    144 (30), 5 (23), SC 13G (22), ARS (16), SD (13), UPLOAD (11), CORRESP (8), S-8 (6), 8-K/A (5), 10-K/A (4), 10-Q/A (3), 3/A (3), SCHEDULE 13G (3), SCHEDULE 13G/A (3), 5/A (2), PRE 14A (2), S-8 POS (2), 144/A (1), 25 (1), 25-NSE (1), 8-A12B (1)

  • Latest filingsAnnual report (10-K) Feb 26, 2026
    Quarterly report (10-Q) Aug 5, 2026
    Proxy statement (DEF 14A) Mar 25, 2026
    Latest 8-K (8-K) Sep 28, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, $1 par valueSCLNew York Stock Exchange

From the cover page of the 10-K filed Feb 26, 2026 (Section 12(b) of the Exchange Act).19

Risk factors and legal proceedings

The risks Stepan Company names in Item 1A of its 10-K filed Feb 26, 2026: 21 risks under these headings, as written.19

  • Business and Operations Risks
  • Chemical manufacturing is inherently hazardous and may result in accidents or may require planned or unplanned production slowdowns or shutdowns, which may disrupt our operations or expose us to significant losses or liabilities that may have a material impact on our business, financial position, results of operations and cash flows.
  • The volatility of raw material, natural gas and electricity costs, as well as any disruption in their supply, may result in increased costs and materially and adversely affect the Company’s business, financial position, results of operations and cash flows.
  • The Company relies heavily on third-party transportation to deliver raw materials to Company manufacturing facilities and ship products to Company customers. Disruptions in transportation or significant changes in transportation costs have affected and could continue to affect the Company’s business, financial position, results of operations and cash flows.
  • Conflicts, military actions, terrorist attacks and general instability, particularly in certain energy-producing nations, along with increased security regulations related to our industry, could adversely affect the Company’s business.
  • Cost overruns, delays and miscalculations in capacity needs with respect to the Company’s expansion or other capital projects could adversely affect the Company’s business, financial position, results of operations and cash flows.
  • We may not realize the anticipated cost savings and/or operating efficiencies associated with strategic initiatives.
  • Market, Competition and Strategic Risks
  • Customer product reformulations or new technologies can reduce the demand for the Company’s existing products, and the Company may not be successful in developing or introducing new products.
  • To the extent the Company seeks acquisition opportunities, it may not be able to make acquisitions of suitable candidates or integrate acquisitions successfully.
  • The Company faces significant global competition in each of its operating segments. If the Company cannot successfully compete in the marketplace, its business, financial position, results of operations and cash flows may be materially and adversely affected.
  • We are affected by general economic conditions and downturns in certain industries, in some cases driven by consumer preferences, and general economic downturns may have an adverse effect on the Company’s business, financial position, results of operations and cash flows.
The other 11 risks
  • If the Company is unable to protect its intellectual property rights, the Company’s ability to compete may be negatively impacted.
  • Regulatory and Legal Risks
  • The Company is subject to a variety of environmental, health and safety and product registration laws dealing with the production and sale of chemicals that could require us to incur additional costs or to reformulate or discontinue certain of our products, or expose us to liability or enforcement actions.
  • Various liability claims could materially and adversely affect the Company’s business, financial position, results of operations and cash flows.
  • The Company’s failure to comply with the anti-corruption laws of the United States and various international jurisdictions could negatively impact its reputation and results of operations.
  • International Operations Risks
  • The Company’s results of operations may be adversely affected by international business risks, including changes in global trade policy, fluctuations in currency exchange rates, legal restrictions and taxes.
  • The international scope of the Company’s operations and corporate structure may expose the Company to potentially adverse tax consequences.
  • Fluctuations in foreign currency exchange rates could affect Company financial results.
  • Financial Risks
  • The Company could be adversely affected by downgrades to its credit ratings or disruptions in its ability to access well-functioning credit markets.
  • The Company has a significant amount of indebtedness and may incur additional indebtedness, or need to refinance existing indebtedness, in the future, which may adversely affect the Company’s business, financial position, results of operations and cash flows.
  • General Risks
  • Interruption of, damage to or compromise of the Company’s information technology (IT) systems, failure to maintain the integrity of customer, colleague or Company data or illegal or fraudulent activities committed against the Company could harm the Company’s reputation and have an adverse effect on the Company’s business, financial position, results of operations and cash flows.
  • The Company’s success depends on its executive management and other key personnel.

Legal proceedings

There are a variety of legal proceedings pending or threatened against the Company that occur in the normal course of the Company’s business, the majority of which relate to environmental assessment, protection and remediation matters. Some of these proceedings may result in fines, penalties, judgments or costs being assessed against the Company at some future time. The Company’s operations are subject to extensive local, state and federal regulations, including the U.S. Comprehensive Environmental Response, Compensation and Liability Act of 1980 (CERCLA) and the Superfund amendments of 1986 (Superfund) as well as comparable regulations applicable to the Company’s foreign locations. Over the years, the Company has received requests for information related to or has been named by government authorities as a potentially responsible party at a number of sites where cleanup costs have been or may be incurred by the Company under CERCLA and similar state statutes. In addition, the Company is from time to time involved in routine legal proceedings incidental to the conduct of its business, including personal injury, property damage, tax, trade and labor matters. The Company believes that it has made adequate provisions for the costs it is likely to incur with respect to these claims. The Company’s material legal proceedings are described below:

Maywood, New Jersey Site

The opening of Item 3, Legal Proceedings.19

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
    SEC EDGAROther events
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91
  92. 92
  93. 93
  94. 94
  95. 95
  96. 96
  97. 97
  98. 98
  99. 99